4
Changes in Ownership
Viridian Therapeutics, Inc.\DE Filed Acc 0000899243-22-039217
General Counsel and Secretary sold 16,926 shares at an average $29.15 ($493,398)
- General Counsel and Secretary acquired 16,926 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Meisner Lara General Counsel and Secretary | 2022-12-20 | Option exercise | +600 | $23.03 | $13,818 | 600 | D |
| Meisner Lara General Counsel and Secretary | 2022-12-20 | Sale | −600 | $28.07 | $16,842 | 0 | D |
| Meisner Lara General Counsel and Secretary | 2022-12-21 | Option exercise | +16,326 | $23.03 | $375,988 | 16,326 | D |
| Meisner Lara General Counsel and Secretary | 2022-12-21 | Sale | −16,326 | $29.19 | $476,556 | 0 | D |
| Derivatives | |||||||
| Meisner Lara General Counsel and Secretary | 2022-12-20 | Option exercise · Stock Option (Right to Buy) | −600 | 61,047 | D | ||
| Meisner Lara General Counsel and Secretary | 2022-12-21 | Option exercise · Stock Option (Right to Buy) | −16,326 | 44,721 | D | ||
| Open-market sales · 16,926 sh · avg $29.15 · $493,398 | |||||||
Loading xslF345X03/doc4.xml…